Itzia Jimenez Ferrer Carrillo (Former)
1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Immunogenetics of Parkinson's disease: Translational studies from rodents to humans
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
- 2018
-
Mark
Microglia in neurological diseases : A road map to brain-disease dependent-inflammatory response
(
- Contribution to journal › Scientific review
-
Mark
Glutathione S-transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Immunogenetics of Parkinson's disease
2018) p.27-44(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder
(
- Contribution to journal › Letter
-
Mark
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism
(
- Contribution to journal › Article
-
Mark
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
(
- Contribution to journal › Article